PharmaFacts for Case Managers

June 2026

Brought to you by the publishers of CareManagement

Read a summary of the essential prescribing information for new FDA-approved drugs in the June issue of PharmaFacts. New drugs include:

Hepcludex for treatment of chronic hepatitis delta
Baxfendy for treatment of hypertension
Immgolis for treatment of rheumatoid arthritis and ulcerative colitis
Immgolis Intri for treatment of rheumatoid arthritis and ulcerative colitis
Trimbow Inhalation Aerosol for asthma maintenance
Beqalzi for treatment of relapsed or refractory mantle cell lymphoma
Veppanu for treatment of breast cancer
Decnupaz Lyophilized Cake for Injection for treatment of plasmacytoid dendritic cell neoplasm

Join ACCM Today

Become a member today to take advantage of the 3 FREE CEs in every issue plus the opportunity to earn the Ethics requirement credits!

New and Improved Format

This is a new and improved format for reading CareManagement!

Classic View

Prefer the classic view? You can download and print a PDF of the current issue by clicking the PDF icon located in the bottom of the digital journal (see below).

Supplements with FREE CEUs

Special CareManagement Supplements – Available to All Case Managers.

Previous PharmaFacts for Case Managers May 2026

Trusted by certified case managers and certified disability management specialists nationwide.

Stay Current.Stay Certified.Join ACCM.

If you are a CCM or CDMS, and you want to stay on the forefront of your practice, plus fulfill your CE requirements on your time and in your space, then ACCM is for you. Join your colleagues today.

Become a Member

Subscribe to our Newsletter